Simulations Plus (NASDAQ:SLP) Downgraded to “Hold” Rating by KeyCorp

Simulations Plus (NASDAQ:SLP) was downgraded by equities research analysts at KeyCorp from an “overweight” rating to a “hold” rating in a research note issued to investors on Monday, Marketbeat.com reports. They presently have a $25.00 price objective on the technology company’s stock, down from their prior price objective of $40.00. KeyCorp’s target price would indicate a potential upside of 92.75% from the stock’s previous close. KeyCorp also issued estimates for Simulations Plus’ Q1 2026 earnings at $0.19 EPS, Q2 2026 earnings at $0.24 EPS, Q3 2026 earnings at $0.23 EPS and FY2027 earnings at $0.96 EPS.

Other research analysts have also issued reports about the company. Craig Hallum decreased their target price on Simulations Plus from $45.00 to $36.00 and set a “buy” rating for the company in a report on Friday, June 13th. JMP Securities reiterated a “market perform” rating on shares of Simulations Plus in a report on Wednesday, June 18th. BTIG Research decreased their price target on Simulations Plus from $41.00 to $25.00 and set a “buy” rating for the company in a report on Monday, July 7th. Wall Street Zen raised Simulations Plus from a “sell” rating to a “hold” rating in a report on Monday, April 28th. Finally, William Blair reaffirmed an “outperform” rating on shares of Simulations Plus in a report on Tuesday, June 3rd. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Simulations Plus currently has an average rating of “Moderate Buy” and an average target price of $26.50.

Simulations Plus Trading Down 25.8%

Shares of NASDAQ SLP opened at $12.97 on Monday. Simulations Plus has a twelve month low of $12.92 and a twelve month high of $44.33. The stock has a fifty day simple moving average of $24.12 and a 200-day simple moving average of $28.18. The stock has a market capitalization of $260.83 million, a PE ratio of -4.12 and a beta of 0.83.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Monday, July 14th. The technology company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.26 by $0.19. The firm had revenue of $20.36 million during the quarter, compared to analyst estimates of $22.83 million. Simulations Plus had a positive return on equity of 10.65% and a negative net margin of 78.63%. Simulations Plus’s revenue was up 9.8% compared to the same quarter last year. During the same period last year, the business posted $0.27 earnings per share. On average, equities analysts predict that Simulations Plus will post 1.09 earnings per share for the current year.

Insider Transactions at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the business’s stock in a transaction dated Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the completion of the sale, the director directly owned 3,344,157 shares of the company’s stock, valued at approximately $112,062,701.07. The trade was a 0.59% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 19.40% of the stock is owned by company insiders.

Institutional Trading of Simulations Plus

Several institutional investors and hedge funds have recently made changes to their positions in SLP. Janus Henderson Group PLC lifted its holdings in shares of Simulations Plus by 7,753.3% in the 4th quarter. Janus Henderson Group PLC now owns 542,899 shares of the technology company’s stock valued at $15,141,000 after purchasing an additional 535,986 shares during the last quarter. Conestoga Capital Advisors LLC lifted its holdings in shares of Simulations Plus by 17.2% in the 1st quarter. Conestoga Capital Advisors LLC now owns 2,609,388 shares of the technology company’s stock valued at $63,982,000 after purchasing an additional 383,126 shares during the last quarter. Royce & Associates LP lifted its holdings in shares of Simulations Plus by 56.6% in the 4th quarter. Royce & Associates LP now owns 371,797 shares of the technology company’s stock valued at $10,369,000 after purchasing an additional 134,381 shares during the last quarter. Kennedy Capital Management LLC lifted its holdings in shares of Simulations Plus by 59.4% in the 4th quarter. Kennedy Capital Management LLC now owns 289,286 shares of the technology company’s stock valued at $8,068,000 after purchasing an additional 107,766 shares during the last quarter. Finally, Wellington Management Group LLP purchased a new stake in shares of Simulations Plus in the 1st quarter valued at about $2,458,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.